Announcement
Smarttech247 Signs 3 Year Deal Worth USD $2.1 Mil
RNS Number : 3071M
Smarttech247 Group PLC
29 April 2024
29 April2024
Smarttech247 Group PLC
("Smarttech247", the "Group" or the "Company")
Smarttech247 Signs Three-Year Deal Worth USD $2.1 million
Smarttech247 (AIM: S247), a multi-award-winning provider of AI-enhanced cybersecurity services providing automated managed detection and response for a portfolio of international clients, is pleased to announce that it has signed a new additional contract with an existing pharmaceuticals solutions client worth USD $2.1 million over three years.
The contract will utilise Smarttech247's partnership agreement with Splunk Inc., which brings together Smarttech247's automation-driven and human-led VisionX managed detection and response (MDR) capabilities and Splunk's powerful security information and event management (SIEM) technology solutions. This collaboration creates an enhanced platform that addresses the evolving needs of a complex and evolving threat landscape.
Raluca Saceanu, CEO of Smarttech247, commented:
"A key pillar of our growth journey is our strategic tech alliances with leading security players that allow us to expand our portfolio internationally, as well as enhance our current solutions. Through our collaboration with Splunk, we can deliver a service that combines our MDR solutions with advanced SIEM technology, empowering our clientele to pinpoint threats with precision whilst optimising their security efficiency.
"As part of this strategy, we are thrilled to announce this most recent contract win with a pre-existing client, a large, pharmaceuticals solutions organisation. This milestone underscores the confidence in Smarttech247 and Splunk's combined capabilities and our dedication to delivering leading cybersecurity solutions."
For further information please contact:
|
Smarttech247 Group PLC |
Tel: +353 21 206 6033 |
|
Ronan Murphy, Executive Chairman Raluca Saceanu, Chief Executive Officer Nicholas Lee, Finance Director |
|
|
SPARK Advisory Partners Limited - Nominated Adviser |
Tel: + 44 (0) 20 3368 3550 |
|
Mark Brady / Adam Dawes |
|
|
Shard Capital - Joint Broker |
Tel: +44 (0) 20 7186 9900 |
|
Damon Heath |
|
|
Fortified Securities - Joint Broker |
Tel: +44 7493 989014 |
|
Guy Wheatley, CFA |
|
|
Yellow Jersey PR Sarah Hollins / Annabelle Wills / Bessie Elliot |
Tel: +44 (0) 20 3004 9512
|
About Smarttech247:
Smarttech247 is a multi-award-winning automated MDR (Managed Detection & Response) company. Its platform is trusted by international organisations and provides threat intelligence with managed detection and response to provide actionable insights, 24/7 threat detection, investigation and response.
The Group's services are geared towards proactive prevention and it achieves this by utilising the latest in cloud, big data analytics and machine learning, along with an experienced incident response team. In recognition of its innovative technology, Smarttech247 was named by Chambers Ireland InBusiness Recognition Awards as Cyber Security Company of the Year 2023.
Smarttech247's offices are located in Ireland, United Kingdom, Romania, Poland and the USA. The Company was admitted to trading on AIM on 15 December 2022.
For further information please visit www.smarttech247.com.
About Splunk Inc.
Splunk Inc. (NASDAQ: SPLK), the cybersecurity and observability leader, helps build a safer and more resilient digital world. Organisations trust Splunk to prevent security, infrastructure and application issues from becoming major incidents, absorb shocks from digital disruptions, and accelerate digital transformation.
For further information, please visit: www.splunk.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
CNTMZGZDVRVGDZM
;